HOME >> MEDICINE >> NEWS
Discovery in 'Bubble Boy' disease gene therapy

Scientists at St. Jude Children's Research Hospital have developed a mouse model of a severe disease of the immune system that helps explain why gene therapy used to treat children with this disease at an institution in Europe caused some of them to develop leukemia. The disease, called X-linked severe combined immunodeficiency (XSCID), is caused by a mutation in a gene called gamma C that prevents the immune system from forming B and T lymphocytes. B lymphocytes produce antibodies, and T lymphocytes perform a variety of tasks such as helping B cells and killing cells that are infected with viruses.

XSCID was made famous by the story of the so-called "Bubble Boy" who lived inside a plastic "bubble" to shield him from infections.

Based on these recent studies, the St. Jude researchers concluded that XSCID itself makes mice--and by extension, children with this disease--particularly susceptible to cancer caused by gene therapy.

One important implication of this finding is that gene therapy for other forms of genetic blood diseases will pose significantly less risk for causing cancer than was previously thought, according to Brian Sorrentino, M.D., director of St. Jude Experimental Hematology Division and co-director of Transplantation and Gene Therapy. Sorrentino is senior author of a report on these findings that appears in the August 1 issue of Proceedings of the National Academy of Sciences.

"Our current findings with this new mouse model offer real hope that we can make gene therapy for X-linked SCID safe as well as effective," said Yan Shou, Ph.D., the paper's first author and the major contributor to this work. XSCID was the first disease ever successfully treated with gene therapy. In 2002, French researchers inserted normal gamma C genes into bone marrow stem cells removed from young children with the disease. The clinicians then infused the genetically modified stem cells back into the patients, restoring the abi
'"/>

Contact: Bonnie Kourvelas
bonnie.kourvelas@stjude.org
901-495-4815
St. Jude Children's Research Hospital
1-Aug-2006


Page: 1 2 3 4

Related medicine news :

1. Discovery of cellular processes which regulate hearts energy supply
2. Discovery of T-cell traffic control boosts new drug promise
3. Mayo collaboration: Discovery blocks breast cancer growth, stimulates immunity
4. Discovery may prevent life-threatening wasting disease in patients with chronic kidney disease
5. Discovery of a drug anticipation brain signal
6. Discovery of key inflammation mechanism in COPD could lead to new treatments
7. Discovery of a molecular switch could lead to new ways of treating infection, including MRSA
8. Bubble Bassets cured of genetic disorder by in-vivo gene therapy technique
9. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
10. Smoking may strongly increase long-term risk of eye disease
11. Pot bellies linked to early signs of cardiovascular disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... August 14, 2018 , ... Health & hygiene ... Report , which is the largest study of brands based on emotions. In the ... in the Top 10 for the health & hygiene industry were: Listerine, Nivea, Gillette, ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com recently ... , What is gout? This painful, persistent condition originates in the liver and ... levels of uric acid. Other contributing factors may be medication side effects, overweight, ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... Lyme disease ... reported per year skyrocketing to an estimated 329,000 – a 25-fold increase since surveillance ... , Lyme disease can be found all 50 states and the District of Columbia. ...
(Date:8/7/2018)... ... August 07, 2018 , ... Josh Sprague, Founder and CEO ... video preview for the upcoming Leadville 100 MTB. , Accompanied by colleague Marvin ... what he has called “one of the most iconic mountain bike race courses in ...
(Date:8/3/2018)... ... ... On August 2, 2018 the JPML ordered that the Zostavax MDL be assigned ... been litigating Zostavax injuries since 2011. , On July ... thousands of people injured by Zostavax, a vaccine given to adults to prevent shingles. ...
Breaking Medicine News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... National Day ... cbdMD named the exclusive sponsor. , “We’re honored to have been selected as ... embrace for CBD on a national level,” said cbdMD’s Chief Scientific Officer, Dr. ...
(Date:8/7/2018)... ... 07, 2018 , ... Penn State graduate, Dr. Kevin Pauza, ... begun training and certifying spine physicians across the United States on his technique ... at the Weill Cornell Brain and Spine Center in July, and have begun ...
(Date:8/3/2018)... (PRWEB) , ... August 03, 2018 , ... Flexefits, a ... passing H.R. 6199, especially for its allowing participants in Direct Primary Care arrangements to ... by HSAs (capped at $150 per individual and $300 per family per month.) , ...
Breaking Medicine Technology:
Cached News: